Skip to main content
. 2016 Jan 27;5(5):806–815. doi: 10.1002/cam4.643

Figure 5.

Figure 5

Overall survival in first‐line metastatic primary efficacy population. (A). Rank‐preserving structural failure time models (RPSFTM) with recensoring. (B). RPSFTM without recensoring. (C). Two‐stage method with recensoring. (D). Two‐stage method without recensoring.